Tag: Insurtech

Browse our exclusive articles!

Investors Betting on AI and Machine Learning with Chips: A Market Map

Discover why investors are putting their money on AI and machine learning chips! Pitchbook's report shows a surge in VC deals worth $14.6B in Q4 2022.

ChatGPT use for underwriting raises concerns

Insurance companies warned about using ChatGPT for underwriting. The tool's reliance on good data makes it unreliable, according to Future Processing's Piotr Piekos. While companies can develop specialized tooling for ChatGPT, it's vital to invest in AI for customers' insurance journeys. This was discussed during a roundtable on the challenges of insurtech opportunities.

Exion Wins APPEALIE Award for Groundbreaking AI and Customer-Friendly SaaS Technology

Exdion Solutions, Inc., a trusted provider of AI-powered insurance software applications, is proud to have won the highly prestigious APPEALIE Award in the SaaS Customer Success category. This recognition celebrates their effort and the positive feedback from their partners. The APPEALIE SaaS Awards are the highest award in the SaaS arena and acknowledge Exdion's innovative platform, reducing operational costs and increasing accuracy. With the upcoming platform launch, brokers can process transactions up to three times faster. Has a 4.6 star rating on software review platforms.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img